ABBOTT LABORATORIES — Director's Dealing 2016

Jul 6, 2016

7/6/2016

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL

OMB Number: 3235-0287

Estimated average burden

hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* Pavee Jean-Yves	2. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President
(Last) (First) (Middle) 100 ABBOTT PARK ROAD	3. Date of Earliest Transaction (Month/Day/Year) 07/01/2016
(Street) ABBOTT PARK IL 60064-6400	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)
Code	V	Amount
Common shares without par value	07/01/2016
Common shares without par value	07/01/2016
Common shares without par value
Common shares without par value
Common shares without par value
Common shares without par value
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)
Code	V	(A)

Explanation of Responses:

1. Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
2. Balance in the Abbott Laboratories Stock Retirement Trust as of July 1, 2016.
3. The reporting person disclaims beneficial ownership of all securities held by his daughter.
4. The reporting person disclaims beneficial ownership of all securities held by his son.

John A. Berry, by power of attorney for Jean-Yves Pavee 07/06/2016

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

https://www.sec.gov/Archives/edgar/data/1800/000117911016027477/xsIF345X03/edgar.xml

---

7/6/2016 SEC FORM 4

https://www.sec.gov/Archives/edgar/data/1800/000117911016027477/xsIF345X03/edgar.xml 2/2